iShares S&P Small-Cap 600 Value
Latest iShares S&P Small-Cap 600 Value News and Updates
What Affected Flotek Industries’ Earnings in 4Q16
In terms of operating income, FTK’s Energy Chemistry Technologies segment fell 34% from 4Q15 to 4Q16.
What Do Analysts Expect from Tidewater’s Fiscal 3Q17 Earnings?
In fiscal 3Q17, analysts expect an ~$1.16 adjusted loss per share for Tidewater. Analysts expect Tidewater’s adjusted loss to fall in the coming quarter.
Will Strategic Alternatives Shape Flotek Industries in 2017?
The Energy Chemistry Technology segment accounted for 76% of Flotek Industries’ revenues in 1Q17. The segment’s revenues rose 36% in 1Q17—compared to 1Q16.
How Is Flotek Industries Positioned to Grow in 2017?
In 2017, crude oil prices have lost nearly 16%, after recovering 45% in 2016.
Which of Flotek Industries’ Segments Has Weakened the Most?
FTK’s segment-wise income We discussed Flotek Industries’ (FTK) revenue in the previous part of this series. Operating income–wise, FTK’s Energy Chemistry Technologies segment fell 56.6% between 3Q15 and 3Q16. In contrast, its Consumer and Industrial Chemistry Technologies segment’s operating income rose ~41%. Between 3Q15 and 3Q16, Flotek Industries’ US revenue fell ~21%. Its revenue from […]
What Affected Flotek Industries in 2Q17?
We’ll now look into Flotek Industries’ (FTK) segment performance in 2Q17. Revenues in the Energy Chemistry Technology (or ECT) segment rose 2% in 2Q17 over a year ago.
This Could Be a Solid Growth Driver for Myriad Genetics in 2018
Myriad Genetics (MYGN) announced the U.S. Food and Drug Administration’s (or FDA) acceptance of its supplementary premarket approval application for BRACAnalysis CDx, a DNA sequencing companion diagnostic test.
Why Flotek Industries’ 4Q17 Earnings Beat Estimates
Flotek Industries (FTK) released its 4Q17 financial results on February 20. The company recorded operating revenues of $72.5 million in 4Q17, up 2.7% from the $70.6 million recorded in 4Q16.
Which Factors Affected Flotek Industries in 3Q16?
Revenues for Flotek’s (FTK) Energy Chemistry Technologies segment fell 25.0% in 3Q16 over a year ago. The segment’s operating income fell 56.6%.
Why Was Tidewater’s Free Cash Flow Negative?
In the first six months of 2017, Tidewater’s free cash flow was -$10 million. Tidewater generated positive free cash flow in fiscal 2016.
Chart in Focus: Spectrum Pharmaceuticals’ Financials
In 3Q17, Spectrum Pharmaceuticals (SPPI) raised $114.0 million from the sale of 12.6 million shares through its security offering program.
Myriad Genetics’ GeneSight: A Major Growth Driver in 2018?
In the first quarter of fiscal 2018, Myriad Genetics’ (MYGN) GeneSight reported revenues of $28.8 million, which is a YoY growth of 54% and a sequential growth of 12%.
Vabomere: Major Addition to The Medicines Company’s Portfolio?
On August 29, 2017, the FDA approved The Medicines Company’s (MDCO) Vabomere for treating adulating patients suffering with complicated urinary tract infections.
Wholesale Drives SuperValu’s Top Line, Retail Stays Muted
Wholesale drives SuperValu’s top line As discussed, SuperValu (SVU) reported its 4Q17 results on April 25. The company returned to growth after several quarters of sales decline. The company’s wholesale segment was the key driver of its 1Q17 top line. Sales from this segment stood at $1.8 billion, up 3% YoY (year-over-year). Revenue growth was […]
Wall Street Expects a 45% Jump in SVU’s Stock Price
Wall Street is quite positive on Supervalu’s (SVU) stock. Analysts are expecting a 45% rise in SVU’s stock price over the next 12 months.
How Has Supervalu’s Stock Performed?
After falling around 30% in 2016, Supervalu’s (SVU) stock continues to be in the red in 2017.
What’s Affecting Flotek Industries’ Revenue
We’ll now look into Flotek Industries’ (FTK) segment performance in 4Q16. The Energy Chemistry Technologies segment accounted for 68% FTK’s 4Q16 revenues.
Wall Street’s Forecasts for Tidewater after Its Fiscal 3Q17 Earnings
According to Reuters, none of the analysts tracking Tidewater (TDW) recommended a “buy” or any equivalent for the stock.
Will Tidewater’s Fiscal 3Q17 Earnings Disappoint?
In fiscal 3Q17, analysts expect $1.16 adjusted loss per share for Tidewater (TDW). Wall Street analysts expect Tidewater’s adjusted loss to deteriorate.
Analyzing Tidewater’s Implied Volatility
Since Tidewater’s fiscal 2Q17 financial results were announced on November 7, 2016, its implied volatility has decreased from 258% to the current level.
What Are Flotek Industries’ Growth Drivers for 4Q16?
Revenues in Flotek Industries’ (FTK) Energy Chemistry Technologies segment fell 25% in 3Q16 over 3Q15.
The Effect of a Credit Facility Agreement on Flotek’s Capex
Flotek Industries’ operating cash flow In this article, we’ll analyze how Flotek Industries’ (FTK) operating cash flow has trended over the past few quarters. We’ll also discuss how its capital expenditure (capex) affected its free cash flow (or FCF). Flotek Industries’ cash from operating activities (or CFO) fell 62% between 3Q15 and 3Q16. FTK generated […]
What’s Affecting Flotek Industries?
Flotek Industries’ revenue growth by segments Flotek Industries’ (FTK) Energy Chemistry Technologies segment accounted for 61% of FTK’s 3Q16 revenue. Revenue in this segment fell 25% between 3Q15 and 3Q16. Flotek Industries makes up 0.15% of the iShares S&P Small-Cap 600 Value ETF (IJS). The energy sector accounts for 4.3% of IJS. The Consumer and […]
ODH’s Credit Rating Downgrade: How’s the OFS Industry Coping?
On November 29, Fitch Rating downgraded the credit rating for Offshore Drilling Holding SA—a Mexican offshore driller.
Tidewater Dodges the Bankruptcy Bullet: For How Long?
On November 11, Tidewater (TDW) received a second extension of waivers against debt covenant compliances until January 27, 2017.
Why Did H.B. Fuller Miss 3Q16 Revenue Estimates?
Analysts had estimated that H.B. Fuller’s (FUL) 3Q16 revenue would be $534.8 million, but it came in at $512.9 million.
Will Flotek Industries’ Capital Expenditure Rise in 2017?
In this article, we’ll analyze how Flotek Industries’ (FTK) operating cash flows have trended over the past few quarters.
What Could Fuel Flotek Industries after 2Q16?
From 2Q15 to 2Q16, all of Flotek Industries’ (FTK) segments except for the Consumer and Industrial Chemical Technologies segment saw lower revenues.